# Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function

> **NCT00887627** · PHASE1 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 25 (actual)

## Conditions studied

- Kidney Diseases
- Hyponatremia

## Interventions

- **DRUG:** conivaptan hydrochloride

## Key facts

- **NCT ID:** NCT00887627
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887627, "Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00887627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*